Comparison of Apolipoprotein B and Low Density Lipoprotein Cholesterol As Atherosclerotic Cardiovascular Risk Factors
CT Acharya, J Zhang, M Esani - American Society for Clinical …, 2019 - clsjournal.ascls.org
Many large-scale studies have reported that current American Heart Association and
American College of Cardiology guidelines overestimate Atherosclerotic Cardiovascular …
American College of Cardiology guidelines overestimate Atherosclerotic Cardiovascular …
Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance …
K Williams, AD Sniderman, N Sattar, R D'Agostino Jr… - Circulation, 2003 - Am Heart Assoc
Background—Risk factors for vascular disease include obesity, dyslipidemia, hypertension,
dysglycemia, insulin resistance, inflammation, thrombosis, and subclinical atherosclerosis …
dysglycemia, insulin resistance, inflammation, thrombosis, and subclinical atherosclerosis …
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk
AD Sniderman, K Williams, JH Contois… - … Quality and Outcomes, 2011 - Am Heart Assoc
Background—Whether apolipoprotein B (apoB) or non-high-density lipoprotein cholesterol
(HDL-C) adds to the predictive power of low-density lipoprotein cholesterol (LDL-C) for …
(HDL-C) adds to the predictive power of low-density lipoprotein cholesterol (LDL-C) for …
Clinical value of apolipoprotein B versus low-density lipoprotein cholesterol in assessing risks of coronary artery disease
S Chen, JZ Zhao, J Hu, ZG Guo - Nan Fang yi ke da xue xue bao …, 2017 - europepmc.org
Objective To compare the value of apolipoprotein B (apoB) and low-density lipoprotein
cholesterol (LDL-C) in assessing the risk of coronary heart disease in patients with …
cholesterol (LDL-C) in assessing the risk of coronary heart disease in patients with …
Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by …
TF Whayne, P Alaupovic, MD Curry, ET Lee… - Atherosclerosis, 1981 - Elsevier
To assess the potential use of plasma apolipoprotein B (ApoB) as a risk factor for coronary
artery disease, this apolipoprotein was quantified by electro-immunoassay in 161 male …
artery disease, this apolipoprotein was quantified by electro-immunoassay in 161 male …
Apolipoprotein B, non‐HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk
S Holewijn, M Den Heijer, DW Swinkels… - Journal of internal …, 2010 - Wiley Online Library
Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AFH, de Graaf J.(Address: Division of
Vascular Medicine, Department of General Internal Medicine; Department of Epidemiology …
Vascular Medicine, Department of General Internal Medicine; Department of Epidemiology …
[PDF][PDF] The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population
R Krittayaphong, C Chotinaiwatarakul… - J Med Assoc …, 2006 - academia.edu
Background: Although direct and calculated low density lipoprotein cholesterol (LDL-
cholesterol) has been widely used as an important predictor for cardiovascular risk, many …
cholesterol) has been widely used as an important predictor for cardiovascular risk, many …
Apolipoprotein B: The Search for a Better Method of Determining ASCVD Risk
RB Daffon - University of Lynchburg DMSc Doctoral …, 2023 - digitalshowcase.lynchburg.edu
Abstract The Centers for Diseases Control and Prevention (CDC) estimates that 12.6 million
adults in the United States (US) are diagnosed with coronary heart disease. Current …
adults in the United States (US) are diagnosed with coronary heart disease. Current …
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
JH Contois, JP McConnell, AA Sethi, G Csako… - 2009 - academic.oup.com
Background: Low-density lipoprotein cholesterol (LDL-C) has been the cornerstone
measurement for assessing cardiovascular risk for nearly 20 years. Content: Recent data …
measurement for assessing cardiovascular risk for nearly 20 years. Content: Recent data …
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk
AD Sniderman, AC St-Pierre, B Cantin… - The American journal of …, 2003 - Elsevier
The objective of the present study was to examine concordance/discordance among 4
atherogenic indexes of cardiovascular risk: plasma total cholesterol, low-density lipoprotein …
atherogenic indexes of cardiovascular risk: plasma total cholesterol, low-density lipoprotein …
Related searches
- risk factors lipoprotein cholesterol
- comparison of apolipoprotein lipoprotein cholesterol
- risk factors comparison of apolipoprotein
- clinical value lipoprotein cholesterol
- artery disease lipoprotein cholesterol
- risk factors male patients
- meta analysis lipoprotein cholesterol
- cardiovascular risk meta analysis
- risk factors artery disease
- risk factors thai population
- ldl cholesterol subclinical atherosclerosis
- disease risk aacc lipoproteins
- hdl cholesterol plasma apolipoprotein
- cardiovascular risk lipoprotein cholesterol
- associations of apolipoprotein lipoprotein cholesterol
- comparison of the associations lipoprotein cholesterol